Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2015 (ALL-MB 2015) (ALL-MB 2015)
Moscow-Berlin 2015 Multicenter Randomized Study for Treatment of Acute Lymphoblastic Leukemia in Children, Adolescents and Young Adults
Sponsor: Federal Research Institute of Pediatric Hematology, Oncology and Immunology
This NA trial investigates Childhood Acute Lymphoblastic Leukemia and is currently ongoing. Federal Research Institute of Pediatric Hematology, Oncology and Immunology leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
8 versions recorded-
Jan 2026 — Present [monthly]
Unknown NA
Status: Recruiting → Unknown
-
Sep 2025 — Jan 2026 [monthly]
Recruiting NA
-
Sep 2024 — Sep 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
-
Jan 2021 — Jul 2024 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Mar 2020 — Jan 2021 [monthly]
Recruiting NA
-
Jun 2018 — Mar 2020 [monthly]
Recruiting NA
-
Jan 2018 — Jun 2018 [monthly]
Recruiting NA
First recorded
Nov 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Federal Research Institute of Pediatric Hematology, Oncology and Immunology
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Arkhangelsk, Russia , Astrakhan, Russia , Barnaul, Russia , Bishkek, Kyrgyzstan , Blagoveshchensk, Russia , Bryansk, Russia , Chelyabinsk, Russia , Chita, Russia , Homyel, Belarus , Irkutsk, Russia and 41 more locations